{"id":"https://openalex.org/W4394847340","doi":"https://doi.org/10.1080/14656566.2024.2343079","title":"An update on antifungal resistance in dermatophytosis","display_name":"An update on antifungal resistance in dermatophytosis","publication_year":2024,"publication_date":"2024-03-23","ids":{"openalex":"https://openalex.org/W4394847340","doi":"https://doi.org/10.1080/14656566.2024.2343079","pmid":"https://pubmed.ncbi.nlm.nih.gov/38623728"},"language":"en","primary_location":{"id":"doi:10.1080/14656566.2024.2343079","doi":"https://doi.org/10.1080/14656566.2024.2343079","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14656566.2024.2343079","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100603158","display_name":"Aditya Kumar Gupta","orcid":"https://orcid.org/0000-0002-8664-7723","observed_orcids":["https://orcid.org/0000-0002-8664-7723"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]},{"id":"https://openalex.org/I4210126549","display_name":"Mediprobe Research (Canada)","ror":"https://ror.org/02x3bf117","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210126549"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Aditya K. Gupta","raw_affiliation_strings":["Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada","Mediprobe Research Inc, London, Ontario, Canada"],"raw_orcid":"https://orcid.org/0000-0002-8664-7723","affiliations":[{"raw_affiliation_string":"Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada","institution_ids":["https://openalex.org/I185261750"]},{"raw_affiliation_string":"Mediprobe Research Inc, London, Ontario, Canada","institution_ids":["https://openalex.org/I4210126549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073064001","display_name":"Avantika Mann","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210126549","display_name":"Mediprobe Research (Canada)","ror":"https://ror.org/02x3bf117","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210126549"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Avantika Mann","raw_affiliation_strings":["Mediprobe Research Inc, London, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mediprobe Research Inc, London, Ontario, Canada","institution_ids":["https://openalex.org/I4210126549"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003625457","display_name":"Shruthi Polla Ravi","orcid":"https://orcid.org/0000-0001-7161-0322","observed_orcids":["https://orcid.org/0000-0001-7161-0322"]},"institutions":[{"id":"https://openalex.org/I4210126549","display_name":"Mediprobe Research (Canada)","ror":"https://ror.org/02x3bf117","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210126549"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Shruthi Polla Ravi","raw_affiliation_strings":["Mediprobe Research Inc, London, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mediprobe Research Inc, London, Ontario, Canada","institution_ids":["https://openalex.org/I4210126549"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5100450974","display_name":"Tong Wang","orcid":"https://orcid.org/0000-0001-9359-9750","observed_orcids":["https://orcid.org/0000-0001-9359-9750"]},"institutions":[{"id":"https://openalex.org/I4210126549","display_name":"Mediprobe Research (Canada)","ror":"https://ror.org/02x3bf117","country_code":"CA","type":"company","lineage":["https://openalex.org/I4210126549"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Tong Wang","raw_affiliation_strings":["Mediprobe Research Inc, London, Ontario, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mediprobe Research Inc, London, Ontario, Canada","institution_ids":["https://openalex.org/I4210126549"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5100603158"],"corresponding_institution_ids":["https://openalex.org/I185261750","https://openalex.org/I4210126549"],"apc_list":null,"apc_paid":null,"fwci":1.8386,"has_fulltext":false,"cited_by_count":26,"citation_normalized_percentile":{"value":0.85470852,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"25","issue":"5","first_page":"511","last_page":"519"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11253","display_name":"Nail Diseases and Treatments","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10150","display_name":"Antifungal resistance and susceptibility","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11037","display_name":"Fungal Infections and Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antifungal-resistance","display_name":"antifungal resistance","score":0.8980000019073486},{"id":"https://openalex.org/keywords/dermatophytosis","display_name":"dermatophytosis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/onychomycosis","display_name":"onychomycosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/trichophyton-mentagrophytes","display_name":"Trichophyton mentagrophytes","score":0.8799999952316284},{"id":"https://openalex.org/keywords/trichophyton-indotineae","display_name":"Trichophyton indotineae","score":0.9819999933242798},{"id":"https://openalex.org/keywords/terbinafine-resistance","display_name":"terbinafine resistance","score":0.9430000185966492},{"id":"https://openalex.org/keywords/itraconazole-resistance","display_name":"itraconazole resistance","score":0.9509999752044678},{"id":"https://openalex.org/keywords/minimum-inhibitory-concentration","display_name":"minimum inhibitory concentration","score":0.9629999995231628},{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":0.6830000281333923},{"id":"https://openalex.org/keywords/superficial-mycoses","display_name":"superficial fungal infections","score":0.6589999794960022},{"id":"https://openalex.org/keywords/dermatophyte-identification","display_name":"dermatophyte identification","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8861826658248901},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.7030445337295532},{"id":"https://openalex.org/C2777071850","wikidata":"https://www.wikidata.org/wiki/Q411229","display_name":"Itraconazole","level":3,"score":0.5135307908058167},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.4453500211238861},{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.427796334028244},{"id":"https://openalex.org/C2778236110","wikidata":"https://www.wikidata.org/wiki/Q415259","display_name":"Terbinafine","level":4,"score":0.4251544177532196},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.36117619276046753},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3593904972076416}],"mesh":[{"descriptor_ui":"D000077291","descriptor_name":"Terbinafine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000077291","descriptor_name":"Terbinafine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003883","descriptor_name":"Arthrodermataceae","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D003883","descriptor_name":"Arthrodermataceae","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008826","descriptor_name":"Microbial Sensitivity Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D014005","descriptor_name":"Tinea","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014005","descriptor_name":"Tinea","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":true},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014009","descriptor_name":"Onychomycosis","qualifier_ui":"Q000382","qualifier_name":"microbiology","is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017964","descriptor_name":"Itraconazole","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D025141","descriptor_name":"Drug Resistance, Fungal","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1080/14656566.2024.2343079","doi":"https://doi.org/10.1080/14656566.2024.2343079","is_oa":false,"landing_page_url":"https://doi.org/10.1080/14656566.2024.2343079","pdf_url":null,"source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:38623728","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/38623728","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":65,"referenced_works":["https://openalex.org/W1133921326","https://openalex.org/W1990102109","https://openalex.org/W2028111549","https://openalex.org/W2129937209","https://openalex.org/W2132112261","https://openalex.org/W2144088019","https://openalex.org/W2153320880","https://openalex.org/W2157946772","https://openalex.org/W2172448890","https://openalex.org/W2528099745","https://openalex.org/W2606000026","https://openalex.org/W2775598628","https://openalex.org/W2783921383","https://openalex.org/W2790695048","https://openalex.org/W2790795010","https://openalex.org/W2803762640","https://openalex.org/W2862769407","https://openalex.org/W2888614890","https://openalex.org/W2896138902","https://openalex.org/W2945199169","https://openalex.org/W3001883794","https://openalex.org/W3003324778","https://openalex.org/W3011204877","https://openalex.org/W3016752752","https://openalex.org/W3034756615","https://openalex.org/W3036059246","https://openalex.org/W3080407494","https://openalex.org/W3081178809","https://openalex.org/W3089012975","https://openalex.org/W3090329576","https://openalex.org/W3118615836","https://openalex.org/W3133511347","https://openalex.org/W3136868899","https://openalex.org/W3163962327","https://openalex.org/W3165041897","https://openalex.org/W3167031870","https://openalex.org/W3176413562","https://openalex.org/W3190186960","https://openalex.org/W3200588778","https://openalex.org/W3200991177","https://openalex.org/W4200196559","https://openalex.org/W4200286236","https://openalex.org/W4210743438","https://openalex.org/W4211051799","https://openalex.org/W4220910541","https://openalex.org/W4221129816","https://openalex.org/W4229657713","https://openalex.org/W4280576625","https://openalex.org/W4292714987","https://openalex.org/W4297995376","https://openalex.org/W4306835838","https://openalex.org/W4308589694","https://openalex.org/W4311134060","https://openalex.org/W4327676747","https://openalex.org/W4366236100","https://openalex.org/W4377151439","https://openalex.org/W4377969189","https://openalex.org/W4378781272","https://openalex.org/W4380785308","https://openalex.org/W4381167512","https://openalex.org/W4382724737","https://openalex.org/W4385651095","https://openalex.org/W4386046018","https://openalex.org/W4389799396","https://openalex.org/W4392183092"],"related_works":["https://openalex.org/W3186829026","https://openalex.org/W3016752752","https://openalex.org/W4400889104","https://openalex.org/W4221129816","https://openalex.org/W4377969189","https://openalex.org/W7166806317","https://openalex.org/W4399294181","https://openalex.org/W2862769407","https://openalex.org/W2022022004","https://openalex.org/W4380785308"],"abstract_inverted_index":{"Introduction":[0],"The":[1,67],"reports":[2],"of":[3,38,103,110,149,158,183,188],"resistance":[4,23,74],"to":[5],"antifungal":[6,22],"agents":[7],"used":[8],"for":[9,52,106,117],"treating":[10],"onychomycosis":[11,78],"and":[12,40,56,60,79,108,113,129,152,155,162,172,181],"other":[13,163],"superficial":[14],"fungal":[15],"infections":[16,136],"are":[17],"increasing.":[18],"This":[19,33],"rise":[20],"in":[21,64,75,95],"poses":[24],"a":[25,138],"public":[26],"health":[27],"challenge":[28],"that":[29],"requires":[30,137],"attention.Areas":[31],"covered":[32],"review":[34],"explores":[35],"the":[36,41,89,96,100,119,159],"prevalence":[37],"dermatophytes":[39],"current":[42],"relationship":[43],"between":[44],"dermatophyte":[45,71,135],"species,":[46],"their":[47],"minimum":[48],"inhibitory":[49],"concentrations":[50],"(MICs)":[51],"terbinafine":[53,107,190],"(an":[54,58],"allylamine)":[55],"itraconazole":[57,192],"azole),":[59],"various":[61],"mutations":[62,94,123],"prevalent":[63,91,121],"these":[65],"species.":[66],"most":[68,90,120],"frequently":[69],"isolated":[70],"associated":[72],"with":[73,77,93],"patients":[76],"dermatophytosis":[80],"was":[81],"T.":[82,85],"mentagrophytes.":[83],"However,":[84],"indotineae":[86],"emerged":[87],"as":[88],"isolate":[92],"SQLE":[97,122,184],"gene,":[98],"exhibiting":[99],"highest":[101],"MIC":[102,179],"8":[104,111],"\u00b5g/ml":[105,112,116],"MICs":[109],"\u2265":[114],"32":[115],"itraconazole.Overall,":[118],"were":[124],"Phe397Leu,":[125],"Leu393Phe,":[126],"Ala448Thr,":[127],"Phe397Leu/Ala448Thr,":[128],"Lys276Asn/Leu415Phe":[130],"(relatively":[131],"recent).Expert":[132],"opinion":[133],"Managing":[134],"personalized":[139],"approach.":[140],"A":[141],"detailed":[142],"history":[143],"should":[144,197],"be":[145,198],"obtained":[146],"including":[147],"details":[148],"travel,":[150],"home":[151],"occupational":[153],"exposure,":[154],"clinical":[156],"examination":[157,170],"skin,":[160],"nails":[161],"body":[164],"systems.":[165],"Relevant":[166],"testing":[167],"includes":[168,178],"mycological":[169],"(traditional":[171],"molecular).":[173],"Additional":[174],"testing,":[175],"where":[176],"available,":[177],"evaluation":[180],"detection":[182],"mutations.":[185],"In":[186],"case":[187],"suspected":[189],"resistance,":[191],"or":[193],"voriconazole":[194],"(less":[195],"commonly)":[196],"considered.":[199]},"counts_by_year":[{"year":2026,"cited_by_count":10},{"year":2025,"cited_by_count":11},{"year":2024,"cited_by_count":5}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-04-17T00:00:00"}